Adjuvant Hepatic Arterial Infusion After Surgery for Four or More Colorectal Liver Metastases - T...

Adjuvant Hepatic Arterial Infusion After Surgery for Four or More Colorectal Liver Metastases  The ASCO Post

Chemotherapy-free adjuvant treatment preserves quality of life in HER2-positive early breast canc...

Chemotherapy-free adjuvant treatment preserves quality of life in HER2-positive early breast cancer  ESMO Daily Reporter

ctDNA-Guided Adjuvant Atezolizumab in Muscle-Invasive Bladder Cancer - The New England Journal of...

ctDNA-Guided Adjuvant Atezolizumab in Muscle-Invasive Bladder Cancer  The New England Journal of Medicine

Polypeptide sono-adjuvant for ultrasound-activatable regulation of innate immunity and cancer vac...

Polypeptide sono-adjuvant for ultrasound-activatable regulation of innate immunity and cancer vaccination therapy  Nature

Adjuvant Pembrolizumab Fails in Phase 3 Liver Cancer Trial - Oncology News Central

Adjuvant Pembrolizumab Fails in Phase 3 Liver Cancer Trial  Oncology News Central

Adjuvant Selpercatinib Improves EFS in Early-Stage RET Fusion–Positive NSCLC - OncLive

Adjuvant Selpercatinib Improves EFS in Early-Stage RET Fusion–Positive NSCLC  OncLive

World-first library of vaccine-enhancing adjuvants launches - CEPI

World-first library of vaccine-enhancing adjuvants launches  CEPI

Adjuvant Pembrolizumab Plus Belzutifan in Patients With RCC at Increased Risk of Recurrence - The...

Adjuvant Pembrolizumab Plus Belzutifan in Patients With RCC at Increased Risk of Recurrence  The ASCO Post

Real-world outcomes following adjuvant chemotherapy for resected pancreatic cancer in a centralis...

Real-world outcomes following adjuvant chemotherapy for resected pancreatic cancer in a centralised oncology service  Nature

Adjuvant Treatment Advances Improve Outcomes in Kidney Cancer but Unmet Needs Persist - OncLive

Adjuvant Treatment Advances Improve Outcomes in Kidney Cancer but Unmet Needs Persist  OncLive

Individualized mRNA vaccines evoke durable T cell immunity in adjuvant TNBC - Nature

Individualized mRNA vaccines evoke durable T cell immunity in adjuvant TNBC  Nature

Adjuvant Aumolertinib in EGFR -Mutated NSCLC - The ASCO Post

Adjuvant Aumolertinib in EGFR -Mutated NSCLC  The ASCO Post

Laser interstitial thermal therapy and adjuvant pembrolizumab in recurrent high-grade astrocytoma...

Laser interstitial thermal therapy and adjuvant pembrolizumab in recurrent high-grade astrocytoma: a Phase 1/randomized Phase 2b trial  Nature

Adjuvant Durvalumab in Resected Early-Stage NSCLC - The ASCO Post

Adjuvant Durvalumab in Resected Early-Stage NSCLC  The ASCO Post

Reconsidering adjuvant and perioperative immune-checkpoint inhibition: de-escalation, expansion a...

Reconsidering adjuvant and perioperative immune-checkpoint inhibition: de-escalation, expansion and personalization  Nature

Long-Term Survival Results With Addition of Adjuvant mFOLFOX6 to Hepatectomy in Patients With Liv...

Long-Term Survival Results With Addition of Adjuvant mFOLFOX6 to Hepatectomy in Patients With Liver Metastases From Colorectal Cancer  The ASCO Post

Low-Risk Endometrial Cancer: Does a Lack of Adjuvant Therapy Affect Survival? - The ASCO Post

Low-Risk Endometrial Cancer: Does a Lack of Adjuvant Therapy Affect Survival?  The ASCO Post

Discovery of a small molecule TLR3 agonist adjuvant - Nature

Discovery of a small molecule TLR3 agonist adjuvant  Nature

Adjuvant Atezolizumab and mFOLFOX6 in Stage III Mismatch Repair–Deficient Colon Cancer - The ASCO...

Adjuvant Atezolizumab and mFOLFOX6 in Stage III Mismatch Repair–Deficient Colon Cancer  The ASCO Post

Circulating tumor DNA-guided adjuvant therapy in locally advanced colon cancer: the randomized ph...

Circulating tumor DNA-guided adjuvant therapy in locally advanced colon cancer: the randomized phase 2/3 DYNAMIC-III trial  Nature

A host-directed adjuvant sensitizes intracellular bacterial persisters to antibiotics - Nature

A host-directed adjuvant sensitizes intracellular bacterial persisters to antibiotics  Nature

Molecular Profile–Based Adjuvant Treatment in High-Intermediate Risk Endometrial Cancer - The ASC...

Molecular Profile–Based Adjuvant Treatment in High-Intermediate Risk Endometrial Cancer  The ASCO Post

Antigen cross-presentation potentiating cancer vaccine adjuvant for T cell expansion and synergy ...

Antigen cross-presentation potentiating cancer vaccine adjuvant for T cell expansion and synergy with anti-PD-1  Nature

Adjuvant Epirubicin Plus Cyclophosphamide Followed by Taxane With or Without Carboplatin in Early...

Adjuvant Epirubicin Plus Cyclophosphamide Followed by Taxane With or Without Carboplatin in Early-Stage Triple-Negative Breast Cancer  The ASCO Post

ASTRO 2025: Bladder Adjuvant Radiotherapy (BART): Clinical Outcomes from a Phase III Multicenter ...

ASTRO 2025: Bladder Adjuvant Radiotherapy (BART): Clinical Outcomes from a Phase III Multicenter Randomized Controlled Trial  UroToday

Tissue-Free ctDNA and Outcomes in Patients With Colorectal Cancer Receiving FOLFOX-Based Adjuvant...

Tissue-Free ctDNA and Outcomes in Patients With Colorectal Cancer Receiving FOLFOX-Based Adjuvant Therapy  The ASCO Post

Adjuvant Pembrolizumab in Merkel Cell Carcinoma - The ASCO Post

Adjuvant Pembrolizumab in Merkel Cell Carcinoma  The ASCO Post

Adjuvant nivolumab for resected high-risk head and neck cancer - The Lancet

Adjuvant nivolumab for resected high-risk head and neck cancer  The Lancet

Platelet-engineered CAR-T cells as adjuvant therapy after cancer surgery - PNAS

Platelet-engineered CAR-T cells as adjuvant therapy after cancer surgery  PNAS

PD-1 Inhibitor Approved for Adjuvant Treatment of CSCC - The ASCO Post

PD-1 Inhibitor Approved for Adjuvant Treatment of CSCC  The ASCO Post

Adjuvant Chemoimmunotherapy for Resected Stage IB–IIIA NSCLC - The ASCO Post

Adjuvant Chemoimmunotherapy for Resected Stage IB–IIIA NSCLC  The ASCO Post

Chronic Toxicity Rates With De-escalated vs Standard Adjuvant Radiotherapy in HPV-Associated Orop...

Chronic Toxicity Rates With De-escalated vs Standard Adjuvant Radiotherapy in HPV-Associated Oropharyngeal Squamous Cell Carcinoma  The ASCO Post

Adjuvant Radiation Therapy Safe and Beneficial in Locally Advanced Muscle-Invasive Bladder Cancer...

Adjuvant Radiation Therapy Safe and Beneficial in Locally Advanced Muscle-Invasive Bladder Cancer  The ASCO Post

Giredestrant Becomes First Oral SERD to Show iDFS Benefit As Adjuvant Therapy in Early ER+, HER2-...

Giredestrant Becomes First Oral SERD to Show iDFS Benefit As Adjuvant Therapy in Early ER+, HER2-Negative Breast Cancer  OncLive

Adjuvant nivolumab and relatlimab in stage III/IV melanoma: the randomized phase 3 RELATIVITY-098...

Adjuvant nivolumab and relatlimab in stage III/IV melanoma: the randomized phase 3 RELATIVITY-098 trial  Nature

An NLRP3-stimulatory adjuvant improves the immunogenicity of influenza virus vaccines in mice and...

An NLRP3-stimulatory adjuvant improves the immunogenicity of influenza virus vaccines in mice and non-human primates  ASM Journals

Sacubitril/Valsartan and Prevention of Cardiac Dysfunction During Adjuvant Breast Cancer Therapy:...

Sacubitril/Valsartan and Prevention of Cardiac Dysfunction During Adjuvant Breast Cancer Therapy: The PRADA II Randomized Clinical Trial  American Heart Association Journals

Adjuvant capecitabine in early-stage triple-negative breast cancer? Yes, but for whom? - The Lancet

Adjuvant capecitabine in early-stage triple-negative breast cancer? Yes, but for whom?  The Lancet

HIV vaccine candidate ΔV1gp120 formulated in ALFQA adjuvant augments mucosal immunity in female m...

HIV vaccine candidate ΔV1gp120 formulated in ALFQA adjuvant augments mucosal immunity in female macaques  Nature

Impact of neoadjuvant and adjuvant chemotherapy on breast cancer prognosis in a propensity score ...

Impact of neoadjuvant and adjuvant chemotherapy on breast cancer prognosis in a propensity score matched population  Nature

Adjuvant activity of a small molecule TLR4 agonist discovered via structure-based virtual screeni...

Adjuvant activity of a small molecule TLR4 agonist discovered via structure-based virtual screening  Nature

Older Women With High-Risk Breast Cancer Addition of Adjuvant Chemotherapy to Hormone Therapy - T...

Older Women With High-Risk Breast Cancer Addition of Adjuvant Chemotherapy to Hormone Therapy  The ASCO Post

10-Year Outcomes With Adjuvant Metronomic Capecitabine in Early Triple-Negative Breast Cancer - T...

10-Year Outcomes With Adjuvant Metronomic Capecitabine in Early Triple-Negative Breast Cancer  The ASCO Post

Implications of the ALINA Trial: Is It Time to Skip Adjuvant Chemotherapy in ALK-Positive NSCLC? ...

Implications of the ALINA Trial: Is It Time to Skip Adjuvant Chemotherapy in ALK-Positive NSCLC?  ASCO Daily News

Rational adjuvant selection for the neonatal period shapes unique and lasting immune polarization...

Rational adjuvant selection for the neonatal period shapes unique and lasting immune polarization in mice  Nature

Adjuvant Abemaciclib Plus Endocrine Therapy Improves OS in High-Risk HR+/HER2– Breast Cancer - On...

Adjuvant Abemaciclib Plus Endocrine Therapy Improves OS in High-Risk HR+/HER2– Breast Cancer  OncLive

Adjuvant Alectinib Impresses in Updated ALINA Results for ALK+ NSCLC - OncLive

Adjuvant Alectinib Impresses in Updated ALINA Results for ALK+ NSCLC  OncLive

Adjuvant ALK TKIs show robust and durable disease-free survival benefit in non-small cell lung ca...

Adjuvant ALK TKIs show robust and durable disease-free survival benefit in non-small cell lung cancer  ESMO Daily Reporter

Age Threshold for Survival Benefit of Adding Oxaliplatin to Adjuvant Chemotherapy in Stage II and...

Age Threshold for Survival Benefit of Adding Oxaliplatin to Adjuvant Chemotherapy in Stage II and III Colorectal Cancer  The ASCO Post

Matrix-M adjuvant triggers inflammasome activation and enables antigen cross-presentation through...

Matrix-M adjuvant triggers inflammasome activation and enables antigen cross-presentation through induction of lysosomal membrane permeabilization  Nature

Adjuvant Chemoradiotherapy vs Radiotherapy for High-Risk Endometrial Cancer: 10-Year PORTEC-3 Out...

Adjuvant Chemoradiotherapy vs Radiotherapy for High-Risk Endometrial Cancer: 10-Year PORTEC-3 Outcomes  The ASCO Post

Enantiomer-dependent and modification-free DNA matrix as an adjuvant for subunit vaccines against...

Enantiomer-dependent and modification-free DNA matrix as an adjuvant for subunit vaccines against SARS-CoV-2 or pneumococcal infections  Nature

Adjuvant chemotherapy and hormonotherapy versus adjuvant hormonotherapy alone for women aged 70 y...

Adjuvant chemotherapy and hormonotherapy versus adjuvant hormonotherapy alone for women aged 70 years and older with high-risk breast cancer based on the genomic grade index (ASTER 70s): a randomised phase 3 trial  The Lancet

Novel Flu Vaccine Adjuvant Improves Protection Against Influenza Viruses, Study Finds - Georgia S...

Novel Flu Vaccine Adjuvant Improves Protection Against Influenza Viruses, Study Finds  Georgia State University News

ctDNA-guided adjuvant chemotherapy in colon cancer: not ready for prime time? - ESMO Daily Reporter

ctDNA-guided adjuvant chemotherapy in colon cancer: not ready for prime time?  ESMO Daily Reporter

Use of Adjuvant Aspirin Reduces the Risk of Recurrence in PI3K -Mutated Colorectal Cancer - The A...

Use of Adjuvant Aspirin Reduces the Risk of Recurrence in PI3K -Mutated Colorectal Cancer  The ASCO Post

Need an adjuvant? Check the library - National Research Council Canada

Need an adjuvant? Check the library  National Research Council Canada

Molecular Assay Identifies Patients With Early NSCLC Likely to Benefit From Adjuvant Chemotherapy...

Molecular Assay Identifies Patients With Early NSCLC Likely to Benefit From Adjuvant Chemotherapy  The ASCO Post

Long term efficacy of adjuvant chemotherapy in elderly patients with early stage breast cancer as...

Long term efficacy of adjuvant chemotherapy in elderly patients with early stage breast cancer assessed through SEER database analysis  Nature

Multiscale dynamic immunomodulation by a nanoemulsified Trojan-TLR7/8 adjuvant for robust protect...

Multiscale dynamic immunomodulation by a nanoemulsified Trojan-TLR7/8 adjuvant for robust protection against heterologous pandemic and endemic viruses | Cellular & Molecular Immunology  Nature

Adjuvant chemotherapy for stage IA–IIA non-squamous, non-small-cell lung cancer identified as mol...

Adjuvant chemotherapy for stage IA–IIA non-squamous, non-small-cell lung cancer identified as molecular high-risk by a 14-gene expression profile (AIM-HIGH): an international, randomised, phase 3 trial  The Lancet

Adjuvant Therapy in Cancer: Benefits, Types, Timing, and Precision-Based Innovations - Oncodaily

Adjuvant Therapy in Cancer: Benefits, Types, Timing, and Precision-Based Innovations  Oncodaily

Adjuvant Cemiplimab in High-Risk Cutaneous Squamous Cell Carcinoma - The ASCO Post

Adjuvant Cemiplimab in High-Risk Cutaneous Squamous Cell Carcinoma  The ASCO Post

ASCO 2025: Adding Atezolizumab to Adjuvant Chemotherapy Improves Disease-Free Survival in dMMR Co...

ASCO 2025: Adding Atezolizumab to Adjuvant Chemotherapy Improves Disease-Free Survival in dMMR Colon Cancer  The ASCO Post

Adjuvant Immunotherapy in High-Risk Cutaneous Squamous Cell Carcinoma - Cleveland Clinic

Adjuvant Immunotherapy in High-Risk Cutaneous Squamous Cell Carcinoma  Cleveland Clinic

C-POST: Adjuvant Cemiplimab Reduces Risk of Recurrence in Patients With High-Risk Cutaneous Squam...

C-POST: Adjuvant Cemiplimab Reduces Risk of Recurrence in Patients With High-Risk Cutaneous Squamous Cell Carcinoma  ASCO Daily News

Calboxyvinyl polymer adjuvant enhances respiratory IgA responses through mucosal and systemic adm...

Calboxyvinyl polymer adjuvant enhances respiratory IgA responses through mucosal and systemic administration  Nature

The scientific journey of a novel adjuvant (AS37) from bench to bedside - Nature

The scientific journey of a novel adjuvant (AS37) from bench to bedside  Nature

Neoadjuvant–Adjuvant or Adjuvant-Only Pembrolizumab in Advanced Melanoma - The New England Journa...

Neoadjuvant–Adjuvant or Adjuvant-Only Pembrolizumab in Advanced Melanoma  The New England Journal of Medicine

Pembrolizumab Is First Adjuvant Therapy to Improve Overall Survival in Kidney Cancer - National C...

Pembrolizumab Is First Adjuvant Therapy to Improve Overall Survival in Kidney Cancer  National Cancer Institute (.gov)

Adjuvant Nivolumab in Resected Esophageal or Gastroesophageal Junction Cancer - The New England J...

Adjuvant Nivolumab in Resected Esophageal or Gastroesophageal Junction Cancer  The New England Journal of Medicine

Overall Survival with Adjuvant Pembrolizumab in Renal-Cell Carcinoma - The New England Journal of...

Overall Survival with Adjuvant Pembrolizumab in Renal-Cell Carcinoma  The New England Journal of Medicine

Adjuvant Immunotherapy in Resected Renal Cell Carcinoma: Déjà vu or Progress? - ASCO Daily News

Adjuvant Immunotherapy in Resected Renal Cell Carcinoma: Déjà vu or Progress?  ASCO Daily News

Adjuvant developed with NIH funding enhances efficacy of India’s COVID-19 vaccine - National Inst...

Adjuvant developed with NIH funding enhances efficacy of India’s COVID-19 vaccine  National Institutes of Health (.gov)

Molecular residual disease analysis of adjuvant osimertinib in resected EGFR -mutated stage IB–II...

Molecular residual disease analysis of adjuvant osimertinib in resected EGFR -mutated stage IB–IIIA non-small-cell lung cancer  Nature

Adjuvant Pembrolizumab after Nephrectomy in Renal-Cell Carcinoma - The New England Journal of Med...

Adjuvant Pembrolizumab after Nephrectomy in Renal-Cell Carcinoma  The New England Journal of Medicine

Adjuvant Chemotherapy Guided by a 21-Gene Expression Assay in Breast Cancer - The New England Jou...

Adjuvant Chemotherapy Guided by a 21-Gene Expression Assay in Breast Cancer  The New England Journal of Medicine

Adjuvant Capecitabine for Breast Cancer after Preoperative Chemotherapy - The New England Journal...

Adjuvant Capecitabine for Breast Cancer after Preoperative Chemotherapy  The New England Journal of Medicine

Adjuvant Olaparib for Patients with BRCA1 - or BRCA2 -Mutated Breast Cancer - The New England Jou...

Adjuvant Olaparib for Patients with BRCA1 - or BRCA2 -Mutated Breast Cancer  The New England Journal of Medicine

Circulating Tumor DNA Analysis Guiding Adjuvant Therapy in Stage II Colon Cancer - The New Englan...

Circulating Tumor DNA Analysis Guiding Adjuvant Therapy in Stage II Colon Cancer  The New England Journal of Medicine

Duration of Adjuvant Aromatase-Inhibitor Therapy in Postmenopausal Breast Cancer - The New Englan...

Duration of Adjuvant Aromatase-Inhibitor Therapy in Postmenopausal Breast Cancer  The New England Journal of Medicine

Adjuvant Chemotherapy for Early-Onset Stage II Colon Cancer - ASCO Publications

Adjuvant Chemotherapy for Early-Onset Stage II Colon Cancer  ASCO Publications

Adjuvant Nivolumab versus Placebo in Muscle-Invasive Urothelial Carcinoma - The New England Journ...

Adjuvant Nivolumab versus Placebo in Muscle-Invasive Urothelial Carcinoma  The New England Journal of Medicine

A particulate saponin/TLR agonist vaccine adjuvant alters lymph flow and modulates adaptive immun...

A particulate saponin/TLR agonist vaccine adjuvant alters lymph flow and modulates adaptive immunity  Science | AAAS

FDA Approves Adjuvant Ribociclib (Kisqali) Plus an Aromatase Inhibitor for Early-Stage Breast Can...

FDA Approves Adjuvant Ribociclib (Kisqali) Plus an Aromatase Inhibitor for Early-Stage Breast Cancer  Oncology News Central

Should Adjuvant Immunotherapy Be Given to Patients With Kidney or Bladder Cancer? - ASCO Daily News

Should Adjuvant Immunotherapy Be Given to Patients With Kidney or Bladder Cancer?  ASCO Daily News

FOLFIRINOX or Gemcitabine as Adjuvant Therapy for Pancreatic Cancer - The New England Journal of ...

FOLFIRINOX or Gemcitabine as Adjuvant Therapy for Pancreatic Cancer  The New England Journal of Medicine

Molecular residual disease and efficacy of adjuvant chemotherapy in patients with colorectal canc...

Molecular residual disease and efficacy of adjuvant chemotherapy in patients with colorectal cancer  Nature

Long-Term Outcomes of Adjuvant Denosumab in Breast Cancer - NEJM Evidence

Long-Term Outcomes of Adjuvant Denosumab in Breast Cancer  NEJM Evidence

Adjuvant nivolumab in resected stage IIB/C melanoma: primary results from the randomized, phase 3...

Adjuvant nivolumab in resected stage IIB/C melanoma: primary results from the randomized, phase 3 CheckMate 76K trial  Nature

Using Clinical Characteristics to Guide Treatment of Recurrent RCC After Adjuvant Pembrolizumab -...

Using Clinical Characteristics to Guide Treatment of Recurrent RCC After Adjuvant Pembrolizumab  ASCO Daily News

Five-Year Analysis of Adjuvant Dabrafenib plus Trametinib in Stage III Melanoma - The New England...

Five-Year Analysis of Adjuvant Dabrafenib plus Trametinib in Stage III Melanoma  The New England Journal of Medicine

Final Results for Adjuvant Dabrafenib plus Trametinib in Stage III Melanoma - The New England Jou...

Final Results for Adjuvant Dabrafenib plus Trametinib in Stage III Melanoma  The New England Journal of Medicine

Where Is the Future of Adjuvant Therapy for Hepatocellular Carcinoma? - ASCO Publications

Where Is the Future of Adjuvant Therapy for Hepatocellular Carcinoma?  ASCO Publications

Human in vitro modeling of adjuvant formulations demonstrates enhancement of immune responses to ...

Human in vitro modeling of adjuvant formulations demonstrates enhancement of immune responses to SARS-CoV-2 antigen | npj Vaccines  Nature

Why We Do Not Recommend That Women With Breast Cancer Receive Adjuvant Treatment With a CDK4/6 In...

Why We Do Not Recommend That Women With Breast Cancer Receive Adjuvant Treatment With a CDK4/6 Inhibitor  ASCO Publications

Alum adjuvant discovery and potency - Nature

Alum adjuvant discovery and potency  Nature

Adjuvant oncolytic virotherapy for personalized anti-cancer vaccination - Nature

Adjuvant oncolytic virotherapy for personalized anti-cancer vaccination  Nature

Adjuvant Chemotherapy plus Radiation for Locally Advanced Endometrial Cancer - The New England Jo...

Adjuvant Chemotherapy plus Radiation for Locally Advanced Endometrial Cancer  The New England Journal of Medicine

A TLR7-nanoparticle adjuvant promotes a broad immune response against heterologous strains of inf...

A TLR7-nanoparticle adjuvant promotes a broad immune response against heterologous strains of influenza and SARS-CoV-2  Nature